Editor's Picks

Open Access Review
3D and 4D printing of biomedical materials: current trends, challenges, and future outlook
Three-dimensional (3D) and four-dimensional (4D) printing have emerged as the next-generation fabrication technologies, covering a broad spectrum of areas, including construction, medicine, transportation, and textiles. 3D printing, also known as additive manufacturing (AM), allows the fabrication of complex structures with high precision via a layer-by-layer addition of various materials. On the other hand, 4D printing technology enables printing smart materials that can alter their shape, properties, and functions upon a stimulus, such as solvent, radiation, heat, pH, magnetism, current, pressure, and relative humidity (RH). Myriad of biomedical materials (BMMs) currently serve in many biomedical engineering fields aiding patients’ needs and expanding their life-span. 3D printing of BMMs provides geometries that are impossible via conventional processing techniques, while 4D printing yields dynamic BMMs, which are intended to be in long-term contact with biological systems owing to their time-dependent stimuli responsiveness. This review comprehensively covers the most recent technological advances in 3D and 4D printing towards fabricating BMMs for tissue engineering, drug delivery, surgical and diagnostic tools, and implants and prosthetics. In addition, the challenges and gaps of 3D and 4D printed BMMs, along with their future outlook, are also extensively discussed. The current review also addresses the scarcity in the literature on the composition, properties, and performances of 3D and 4D printed BMMs in medical applications and their pros and cons. Moreover, the content presented would be immensely beneficial for material scientists, chemists, and engineers engaged in AM manufacturing and clinicians in the biomedical field.
Open Access Original Article
A large-scale survey of cannabis use for sleep: preferred products and perceived effects in comparison to over-the-counter and prescription sleep aids
Aim: Cannabis use for sleep-related problems is on the rise; however, little is known about the cannabis products people are using for sleep or the perceived effects of cannabis in comparison to more conventional sleep aids. Therefore, the aim of this study was to examine the products cannabis users prefer to use for sleep as well as their experiences with cannabis relative to more conventional sleep aids. Methods: De-identified archival data from a Strainprint® survey of 1,216 individuals who use cannabis for sleep were analyzed. Results: Participants predominantly reported smoking joints or vaping flower as their methods of administration, and seeking tetrahydrocannabinol (THC), cannabidiol (CBD), and the terpene myrcene in the cannabis they use for sleep. Only a small minority reported using cannabis in conjunction with conventional sleep aids. Comparisons of the self-reported effects of cannabis to conventional sleep aids revealed that participants reported feeling more refreshed, focused, better able to function, fewer headaches, and less nausea the morning after using cannabis for sleep than after using more conventional sleep aids or no sleep aids. However, they indicated they were more sleepy, anxious, and irritable in the mornings following the use of cannabis relative to other sleep aids. Participants were more likely to report red eyes and thirst and less likely to report nausea, anxiety, paranoia, and racing heart as side effects of cannabis relative to other sleep aids. Conclusions: Knowledge gained from this survey will provide health professionals with a better understanding of why people are using cannabis for sleep and may help guide future more controlled research.
Open Access Review
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin
The pathophysiological mechanisms underlying the close relationship between nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are multiple, complex and only partially known. The purpose of this paper was to review the current knowledge of these mechanisms in a unified manner. Subjects with NAFLD and T2DM have established insulin resistance (IR), which exacerbates the two comorbidities. IR worsens NAFLD by increasing the accumulation of free fatty acids (FFAs) in the liver. This occurs due to an increase in the influx of FFAs from peripheral adipose tissue by the activation of hormone-sensitive lipase. In addition, there is de novo increased lipogenesis, a transcription factor, the sterols regulatory element-binding transcription factor 1c (SREBP-1c), which activates the expression of several genes strongly promotes lipogenesis by the liver and facilitate storage of triglycerides. Lipids accumulation in the liver induces a chronic stress in the endoplasmic reticulum of the hepatocytes. Genome-wide association studies have identified genetic variants associated with NAFLD severity, but unrelated to IR. In particular, the alteration of patatin-like phospholipase domain-containing protein 3 contributes to the susceptibility to NAFLD. Furthermore, the lipotoxicity of ceramides and diacylglycerol, well known in T2DM, triggers a chronic inflammatory process favoring the progression from hepatic steatosis to steatohepatitis. Reactive oxygen species produced by mitochondrial dysfunction trigger both liver inflammation and beta-cells damage, promoting the progression of both NAFLD and T2DM. The close association between NAFLD and T2DM is bidirectional, as T2DM may trigger both NAFLD onset and its progression, but NAFLD itself may contribute to the development of IR and T2DM. Future studies on the mechanisms will have to deepen the knowledge of the interaction between the two pathologies and should allow the identification of new therapeutic targets for the treatment of NAFLD, currently substantially absent.

Articles

Latest
Most Viewed
Most Downloaded
Most Cited
Open Access Review
TMAO metaorganismal pathway and chronic inflammatory diseases
Zeneng Wang ... Robert Koeth
Published: June 23, 2025 Explor Med. 2025;6:1001339
73 7 0
Open Access Original Article
Impact of BMI on IL-6 and IL-18 levels in children and adolescents with asthma
Regina N. Khramova ... Olga V. Khaletskaya
Published: June 23, 2025 Explor Med. 2025;6:1001338
58 4 0
Open Access Perspective
Closing gaps in blood pressure control: a look at two major approaches
Shawna D. Nesbitt
Published: June 23, 2025 Explor Med. 2025;6:1001337
This article belongs to the special issue Drug Adherence in Hypertension
56 3 0
Open Access Review
Microbiota recruitment for brain cancer management
Ruty Mehrian-Shai
Published: June 20, 2025 Explor Med. 2025;6:1001335
This article belongs to the special issue Personalized Medicine in Cancer Therapy
143 3 0
Open Access Review
Liver and obesity: a narrative review
Amedeo Lonardo, Ralf Weiskirchen
Published: June 18, 2025 Explor Med. 2025;6:1001334
199 16 0
Open Access Review
The potential anti-cancer effects of melatonin on breast cancer
Naba Kumar Das, Saptadip Samanta
Published: February 25, 2022 Explor Med. 2022;3:112–127
22807 285 4
Open Access Review
3D printing in biomedicine: advancing personalized care through additive manufacturing
Kalyani Pathak ... Barbie Borthakur
Published: December 29, 2023 Explor Med. 2023;4:1135–1167
22504 342 45
Open Access Review
The gut microbiome and the immune system
Tenzin Choden, Nathaniel Aviv Cohen
Published: May 31, 2022 Explor Med. 2022;3:219–233
21156 510 13
Open Access Original Article
Cannabis use in cancer patients: acute and sustained associations with pain, cognition, and quality of life
Gregory Giordano ... Angela D. Bryan
Published: April 26, 2023 Explor Med. 2023;4:254–271
This article belongs to the special issue Beyond Weed: Clinical Applications of Cannabis and Cannabinoids
16180 290 6
Open Access Review
Reactive oxygen species in cancer progression and its role in therapeutics
Ranjeet Singh, Partha Pratim Manna
Published: February 22, 2022 Explor Med. 2022;3:43–57
This article belongs to the special issue Reactive Oxygen Species (ROS) in Pathophysiological Conditions
14561 402 44
Open Access Review
Roles of poly(ADP-ribose) polymerase 1 and mitophagy in progeroid syndromes as well as physiological ageing
Naoko Suga ... Satoru Matsuda
Published: October 31, 2023 Explor Med. 2023;4:822–838
This article belongs to the special issue Determinants of Exceptional Longevity
3198 906 1
Open Access Review
The gut microbiome and the immune system
Tenzin Choden, Nathaniel Aviv Cohen
Published: May 31, 2022 Explor Med. 2022;3:219–233
21156 510 13
Open Access Review
Reactive oxygen species in cancer progression and its role in therapeutics
Ranjeet Singh, Partha Pratim Manna
Published: February 22, 2022 Explor Med. 2022;3:43–57
This article belongs to the special issue Reactive Oxygen Species (ROS) in Pathophysiological Conditions
14561 402 44
Open Access Review
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin
Carlo Acierno ... Ferdinando Carlo Sasso
Published: October 30, 2020 Explor Med. 2020;1:287–306
This article belongs to the special issue Exploring NAFLD/NASH
10369 359 56
Open Access Review
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin
Carlo Acierno ... Ferdinando Carlo Sasso
Published: October 30, 2020 Explor Med. 2020;1:287–306
This article belongs to the special issue Exploring NAFLD/NASH
10369 359 56
Open Access Review
3D printing in biomedicine: advancing personalized care through additive manufacturing
Kalyani Pathak ... Barbie Borthakur
Published: December 29, 2023 Explor Med. 2023;4:1135–1167
22504 342 45
Open Access Review
Reactive oxygen species in cancer progression and its role in therapeutics
Ranjeet Singh, Partha Pratim Manna
Published: February 22, 2022 Explor Med. 2022;3:43–57
This article belongs to the special issue Reactive Oxygen Species (ROS) in Pathophysiological Conditions
14561 402 44
Open Access Review
PNPLA3 gene and kidney disease
Alessandro Mantovani, Chiara Zusi
Published: February 29, 2020 Explor Med. 2020;1:42–50
5128 82 34
Open Access Review
Nonalcoholic fatty liver disease and portal hypertension
Marvin Ryou ... Gyorgy Baffy
Published: June 29, 2020 Explor Med. 2020;1:149–169
This article belongs to the special issue Exploring NAFLD/NASH
10147 142 29
Open Access Original Article
Identification of digital voice biomarkers for cognitive health
Honghuang Lin ... Rhoda Au
Published: December 31, 2020 Explor Med. 2020;1:406–417
This article belongs to the special issue Digital Biomarkers: The New Frontier for Medicine and Research
5450 112 27

Special Issues

Ongoing Special lssues
Completed Special lssues
Artificial Intelligence in Precision Imaging: Innovations Shaping the Future of Clinical Diagnostics
Dr. Michaela Cellina
January 31, 2026
Published Articles: 0
Practical Tips for Cancer Care: Guidance for Patients, Caregivers, and Healthcare Professionals
Prof. Patricia Tai
September 30, 2025
Published Articles: 0
Assessment of Atrial and Ventricular Volumes and Functional Properties: Novel Insights
Prof. Attila Nemes
August 31, 2025
Published Articles: 0
Lipid Peroxidation and Cancer
Prof. Neven Zarkovic
July 31, 2025
Published Articles: 0
Innovative Approaches to Chronic Pain Management: from Multidisciplinary Strategies to Artificial Intelligence Perspectives
Prof. Marco Cascella
August 31, 2025
Published Articles: 2
Global Perspectives on the Clinical Diagnosis, Treatment, and Functional Cure of HIV Infection in the Post-ART Era
Prof. Hongzhou Lu
July 31, 2025
Published Articles: 2
Molecular Diagnostics in Oncology
Prof. Evgeny Imyanitov
July 31, 2025
Published Articles: 3
Advances in Oral Cancer: Prevention, Diagnosis, and Therapeutics
Dr. Luca Fiorillo
July 31, 2025
Published Articles: 4
Artificial Intelligence and Machine Learning in Cardiovascular Medicine
Prof. Zhong Wang Dr. Ienglam Lei Dr. Liu Liu
August 31, 2025
Published Articles: 1
Prostate Specific Membrane Antigen (PSMA) in Prostate Cancer
Dr. Finn Edler von Eyben
June 30, 2025
Published Articles: 0
Neurophysiological Mechanisms of Aging and Dementia
Prof. Fabrizio Vecchio
May 31, 2025
Published Articles: 5
Personalized Medicine in Cancer Therapy
Prof. Haim Werner Prof. Ilan Bruchim
June 30, 2025
Published Articles: 1
Spotlight on Cervical Cancer: Prevention, Early-Diagnosis, and Treatments
Dr. Andrea Giannini Dr. Giorgio Bogani
May 31, 2025
Published Articles: 4
Drug Adherence in Hypertension
Prof. Sverre E. Kjeldsen
April 30, 2025
Published Articles: 7
Emerging Infectious Diseases
Prof. Marcos Roberto Tovani-Palone
June 30, 2025
Published Articles: 5
Gut Microbiota Derived Metabolites and Chronic Inflammatory Diseases
Dr. Zeneng Wang
May 31, 2025
Published Articles: 6
Lung Fibrosis—Models and Mechanisms
Prof. Bernhard Ryffel
June 30, 2025
Published Articles: 4

Membership

Journal Indexing
Journal Metrics
Speed 2025

From Submission to First Decision: 10 days

From First decision to Acceptance: 75 days

From Acceptance to Publication: 24 days

Article Usage (total)

Views: 1,162,316

Downloads: 26,097

Acceptance Rate

20%; 2024

21%; 2023

32%; 2022

Follow the Journal